2nd World Congress on Clinical Trials in Diabetes, Berlin 2017
- Start Date:
- Monday, 27 November, 2017
- End Date:
- Tuesday, 28 November, 2017 5:00pm
- Health & Nutrition
It is clear that there is a continuing necessity to streamline these issues into a process that will improve drug development in terms of approval and commercialization, and address the various aspects of drug and device development and the way to enhance them. Once again, our world renowned faculty will tackle issues head, on through a comprehensive program which will focus on key areas including: Design the Best StudyImprove Regulatory ProcessBetter Understanding of How to Collaborate with Regulatory AuthoritiesInvolvement of Digital MedicineManagement of Diabetes and Personalized Medicine The scientific program will have a broad therapeutic focus and tackle both the global and specific regional differences.
The program will include speakers such as physicians, RandD personnel, regulatory decision makers, CEOs, CROs, CRAs, Clinical Trial Managers and QA personnel. You are invited and encouraged to contribute to the program by submitting abstracts for poster presentation and we look forward to your active involvement. We look forward to seeing you at WCTD2017 in the exciting and historical city of Berlin, which provides an unforgettable backdrop for the Congress.
For Sponsorship and Exhibition opportunities, contact Joanne@bioevents-congress.com Special rates are offered for start-ups. contact us for more information firstname.lastname@example.org Speakers: Itamar Raz, Philip Home, Oilver Schnell, Ralph DeFronzo, Stefano del Prato, Roy Eldor, Markolf Hanefeld, Hiddo Lambers Heerspink, John Lachin, James Nolan, Andreas Pfützner, Paolo Pozzilli, Eberhard Standl, Giuseppe M.C. Rosano, Jane EB Reusch
Conference organized by Bioevents